In vivo and in vitro splicing assay of SLC12A1 in an antenatal salt-losing tubulopathy patient with an intronic mutation

被引：0
作者：
Kandai Nozu
Kazumoto Iijima
Kazuo Kawai
Yoshimi Nozu
Atsushi Nishida
Yasuhiro Takeshima
Xue Jun Fu
Yuya Hashimura
Hiroshi Kaito
Koichi Nakanishi
Norishige Yoshikawa
Masafumi Matsuo
机构：
[1] Kobe University Graduate School of Medicine,Department of Pediatrics
[2] Matsusaka City Hospital,Department of Pediatrics
[3] Wakayama Medical University,Department of Pediatrics
来源：
Human Genetics | 2009年 / 126卷
关键词：
SLC12A1 Gene; Splice Donor Site; Alport Syndrome; Polyhydramnios; Bartter Syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Type I Bartter syndrome (BS), an inherited salt-losing tubulopathy, is caused by mutations of the SLC12A1 gene. While several intronic nucleotide changes in this gene have been detected, transcriptional analysis had not been conducted because mRNA analysis is possible only when renal biopsy specimens can be obtained or occasionally when mRNA is expressed in the leukocytes. This report concerns a type I BS patient due to compound heterozygosity for the SLC12A1 gene. Genomic DNA sequencing disclosed the presence of two novel heterozygous mutations of c.724 + 4A > G in intron 5 and c.2095delG in intron 16, but it remains to be determined whether the former would be likely to influence the transcription. In this report, we conducted both in vivo assay of RT-PCR analysis using RNA extracted from the proband’s urinary sediments and in vitro functional splicing study by minigene construction, and obtained evidence that this intronic mutation leads to complete exon 5 skipping. To the best of our knowledge, this is the first study to use non-invasive methods for both an in vivo assay and an in vitro functional splicing assay of inherited kidney disease. These analytical assays could be adapted for all inherited kidney diseases.
引用
收藏
页码：533 / 538
页数：5
相关论文
共 50 条
  • [11] Inatomi J(1997)Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III Nat Genet 17 171-178
  • [12] Ohara T(1995)Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe J Clin Invest 95 515-520
  • [13] Iida K(2005)A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro Mol Genet Metab 85 213-219
  • [14] Nozu K(2006)Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene J Med Genet 43 924-930
  • [15] Takahashi Y(2007)A nonsense mutation-created intraexonic splice site is active in the lymphocytes, but not in the skeletal muscle of a DMD patient Hum Genet 120 737-742
  • [16] Kaito H(1998)Novel molecular variants of the Na–K–2Cl cotransporter gene are responsible for antenatal Bartter syndrome Am J Hum Genet 62 1332-1340
  • [17] Nozu K(2004)Systematic identification and analysis of exonic splicing silencers Cell 119 831-845
  • [18] Fu XJ(undefined)undefined undefined undefined undefined-undefined
  • [19] Krol RP(undefined)undefined undefined undefined undefined-undefined
  • [20] Nozu K(undefined)undefined undefined undefined undefined-undefined
12345